Suchergebnisse - "Elzein, Fatehi"

PubPharm (7)

1

Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta-1b in MIRACLE clinical trial

enthalten in: Influenza and other respiratory viruses | 2023

von Alotaibi, F. | Alharbi, N. | Rosen, L. | +25

2

Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta‐1b in MIRACLE clinical trial

enthalten in: Influenza and Other Respiratory Viruses | 2023

von Alotaibi, F. | Alharbi, N. | Rosen, L. | +24

3

Efficacy of tocilizumab in patients with severe COVID-19 : Survival and clinical outcomes

enthalten in: Journal of infection and public health | 2021

von Al-Baadani, A. | Eltayeb, N. | Alsufyani, E. | +11

4

Reinfection, recurrence, or delayed presentation of COVID-19? Case series and review of the literature

enthalten in: Journal of infection and public health | 2021

von Elzein, F. | Ibrahim, A. | Alshahrani, F. | +9

5

COVID-19 co-infection in a patient with brucella bacteremia

enthalten in: Respiratory medicine case reports | 2020

von Elzein, F. | Alsherbeeni, N. | Almatrafi, K. | +2

6

Characteristics and outcome of viral pneumonia caused by influenza and Middle East respiratory syndrome-coronavirus infections : A 4-year experience from a tertiary care center

enthalten in: Annals of thoracic medicine | 2019

von Al-Baadani, A. | Elzein, F. | Alhemyadi, S. | +3

7

Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial) : study protocol for a randomized controlled trial

enthalten in: Trials | 2018

von Arabi, Y. | Alothman, A. | Balkhy, H. | +103

1
[1]